Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
AP fil
The Food and Drug Administration may beat last year's track record for approving new generic drugs, according to the Regulatory Affairs Professionals Society. With two months left in fiscal 2017, the agency has already approved 633 generic drugs compared to the 651 it approved in all of fiscal 2016.
Why it matters: It's a clear improvement for an agency that has been under pressure to clear a backlog of unapproved drug applications. FDA Commissioner Scott Gottlieb has said he wants to speed the approval of generic drugs to help bring down drug prices by creating more competition.